Considering cadherin immunoexpression in all primary melanomas studied, tumors with high N-cadherin expression scores (3 and 4) exhibited a significantly shorter survival time, with a median of 4 months, compared to tumors with low expression scores (0, 1, and 2) (p = 0.0410). This evidence concerns the gene CDH17 and melanoma.